Fariba Saghafifar

845 citations
6 papers · 630 indexed · h-index 5
Topics
Multiple Myeloma Research and Treatments (3 papers)Heparin-Induced Thrombocytopenia and Thrombosis (2 papers)Cancer Treatment and Pharmacology (2 papers)
Partner nations
United States

In The Last Decade

Fariba Saghafifar

6 papers receiving 610 citations

Peers

Fariba Saghafifar
Comparison fields: 5 of 53
  • Hematology 439
  • Internal Medicine 201
  • Oncology 190
  • Genetics 188
  • Molecular Biology 174
Replace Jonathan P. Kerr with:
Jonathan P. Kerr United Kingdom
Silvia Crestani Italy
David A. Manly United States
Sam L. Glover United States
Mary Ann Karam United States
T. Eng Gan Australia
E. Jakobsen Norway
Ken Kaito Japan
Dana E. Angelini United States
D. Anthony Barcel United States
Fariba Saghafifar relative to Jonathan P. Kerr United Kingdom Jonathan P. Kerr's profile →
Citations per field
00.5×4.0×
Jonathan P. Kerr · 1×
Citations per year

Countries citing papers authored by Fariba Saghafifar

Since Specialization
Citations

This map shows the geographic impact of Fariba Saghafifar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fariba Saghafifar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fariba Saghafifar more than expected).

Fields of papers citing papers by Fariba Saghafifar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fariba Saghafifar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fariba Saghafifar. The network helps show where Fariba Saghafifar may publish in the future.

Co-authorship network of co-authors of Fariba Saghafifar

This figure shows the co-authorship network connecting the top 25 collaborators of Fariba Saghafifar. A scholar is included among the top collaborators of Fariba Saghafifar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fariba Saghafifar. Fariba Saghafifar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 102
2 168
3 65
4 107
5 186
6
Results of phase I study of CC-5013 for the treatment of multiple myeloma patients who relapse after high dose chemotherapy
2

About Fariba Saghafifar

Fariba Saghafifar is a scholar working on Internal Medicine, Hematology and Oncology, having authored 6 papers that have together received 630 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Internal Medicine (201 citations), Hematology (439 citations) and Genetics (188 citations). Fariba Saghafifar has collaborated with scholars based in United States. Frequent co-authors include Guido Tricot, Maurizio Zangari, Louis M. Fink, Athanasios Fassas, Bart Barlogie, Elias Anaissie, Christopher Morris, Eric R. Siegel, Paulette Mehta and E. Anaissie. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026